Yves Levy, 1 the data demonstrate the ability of CD40.HIVRI.Env ... Vaccines (AMVs), a novel class of immunotherapy fusing the power of antibodies and vaccines. AMV candidates engage, prime and ...
Findings in HIV highlight AMV technology's versatility, robust immune response, and excellent safety profile, underpinning company's expansion into oncology applications Paris, France - March 13, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback